AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19047294
Drug: High-dose combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose combination (two courses)
Trial: 17459189
Drug: Low-fat milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat milk with added 20 mmol/l NaCl
Trial: 16425789
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg once daily for 6 weeks
Trial: 12002729
Drug: 10mg Montelukast
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10mg Montelukast (ML) + 10mg Loratadine (LT)
Trial: 1923171
Drug: No transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No transdermal scopolamine (Control)
Trial: 7040956
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside infusion for 48 hours
Trial: 7040956
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside infusion started within nine hours of onset of pain
Trial: 7040956
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside infusion started later than nine hours of onset of pain
Trial: 29368902
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution as an irrigant during surgical extraction and mouthwash for a week after extraction.
Trial: 22249475
Drug: Zinc (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (40 mg twice weekly)
Trial: 11709566
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (four cycles of fluorouracil, epirubicin, and cyclophosphamide)
Trial: 17154437
Drug: Clonazepam test
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonazepam test formulation from Ranbaxy Laboratories Ltd (2 mg)
Trial: 17154437
Drug: Rivotril from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivotril from Roche Laboratórios Ltda (2 mg)
Trial: 15688960
Drug: Daily flossing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily flossing regime
Trial: 12208408
Drug: Amiodarone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (300 mg over 10 minutes)
Trial: 12208408
Drug: Ibutilide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide (1 mg over 5 minutes)
Trial: 9803987
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg) with ferrous sulphate (300 mg)
Trial: 24193079
Drug: Nondepressed Patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondepressed Patients (Clinician-reported antidepressant prescribing)
Trial: 24193079
Drug: Nondepressed Patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondepressed Patients (Patient-reported antidepressant recommendation)
Trial: 19644849
Drug: Golimumab 100
RxNorm normalized name: golimumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golimumab 100 mg plus MTX
Trial: 19644849
Drug: Combined golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Combined golimumab groups (50 mg + MTX and 100 mg + MTX)
Trial: 14665448
Drug: Dexamethasone 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 2.0 mg orally
Trial: 11703573
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy (IFN)
Trial: 9380826
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment couch
Trial: 7898001
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of antibiotics for treatment of the recurrence
Trial: 31267277
Drug: Reflexology intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reflexology intervention (4 weekly sessions, 30-min protocol)
Trial: 25424947
Drug: A/H1N1 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A/H1N1 vaccine formulations with varying antigen quantity (3.75 µg to 30 µg of hemagglutinin) and MF59(®) adjuvant (none, half dose, or full dose)
Trial: 25424947
Drug: A single
RxNorm normalized name: Hemoccult Sensa Single Slide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A single vaccine dose containing 3.75 µg of A/California/7/2009 (H1N1) antigen with MF59 adjuvant
Trial: 24360042
Drug: Modified balloon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified balloon dilatation and traditional swallowing therapy (E-stim, Mendelsohn Maneuver, supraglottic swallowing) for 3 weeks
Trial: 24360042
Drug: Traditional swallowing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional swallowing therapy for 3 weeks
Trial: 21827440
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg/kg (group SP2)
Trial: 21827440
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg/kg (group SP1)
Trial: 18279736
Drug: On-treatment triglycerides
RxNorm normalized name: CAPRYLIC TRIGLYCERIDE
DrugBank: Tricaprylin (DB12176)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-treatment triglycerides (TG) <150 mg/dl
Trial: 18279736
Drug: Each 10
RxNorm normalized name: ClindaReach 10 MG/ML Medicated Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Each 10 mg/dl decrement in on-treatment TG
Trial: 18279736
Drug: TG <150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TG <150 mg/dl and LDL-C <70 mg/dl
Trial: 18279736
Drug: Low on-treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low on-treatment TG, LDL-C, and C-reactive protein (<2 mg/l)
Trial: 16545135
Drug: Random gentamicin
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Random gentamicin concentration measured 4-20 hours after administration
Trial: 15023597
Drug: High meat
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High meat diet (HM) for subjects with high triglycerides (>1.5mmol/L)
Trial: 7564674
Drug: Azithromycin 20
RxNorm normalized name: azithromycin 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 20 mg/kg weekly (days 1, 8, and 15)
Trial: 7564674
Drug: Tetracycline eye
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline eye ointment (days 1-42)
Trial: 1688482
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg of sotalol administered twice daily
Trial: 1688482
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of propranolol administered 3 times daily
Trial: 1688482
Drug: 320 mg
RxNorm normalized name: aspirin 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 320 mg of sotalol administered twice daily
Trial: 1688482
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of propranolol administered 3 times daily
Trial: 26117466
Drug: 180 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 mg loading dose (LD) of ticagrelor
Trial: 26117466
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg maintenance dose (MD) of ticagrelor
Trial: 23229236
Drug: Anesthetic blockage
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthetic blockage of the auriculotemporal nerve with injections of 1 ml of bupivacaine 0.5% without vasoconstrictor for 8 weeks (group 1)
Trial: 23229236
Drug: Anesthetic blockage
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthetic blockage and physical therapy (massage and muscular stretching exercises) (group 2)
Trial: 16690431
Drug: Iodine (131I)
RxNorm normalized name: Iodine (131I) compounds
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine (131I) metuximab injection (27.75 MBq/kg)
Trial: 15066459
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of sildenafil citrate (VIAGRA)
Trial: 2567579
Drug: H1 receptor
RxNorm normalized name: Histamine H1 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1 receptor antagonist, levocabastine
Trial: 2567579
Drug: H2 receptor
RxNorm normalized name: Histamine H2 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2 receptor antagonist, ranitidine
Trial: 2567579
Drug: H1 and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1 and/or H2 antagonists
Trial: 27798730
Drug: Apatinib treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib treatment
Trial: 26295507
Drug: Hydrocortisone cream
RxNorm normalized name: Hydrocortisone Cream
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone cream
Trial: 26295507
Drug: No cream
RxNorm normalized name: Oil, Multi Ingredient Topical application Oil [AVEENO CREAMY MOISTURIZING OIL]
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No cream application (Control)
Trial: 15181058
Drug: Combined hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormone therapy (CHT) - continuous conjugated equine estrogen/cyclical micronized progesterone for 3 months
Trial: 10886121
Drug: Yohimbine 22
RxNorm normalized name: YOHIMBINE
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine 22 mg
Trial: 10886121
Drug: Clonidine 0.2
RxNorm normalized name: CLONIDINE 0.2MG/24HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.2 mg + Yohimbine 22 mg
Trial: 11480052
Drug: Dobell's solution
RxNorm normalized name: Dobell's Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobell's solution (control group 1, 29 patients)
Trial: 11480052
Drug: Koutai solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Koutai solution (control group 2, 30 patients)
Trial: 8513841
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose hamamelis PC-cream
Trial: 8513841
Drug: Hamamelis cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hamamelis cream (without PC)
Trial: 8513841
Drug: Chamomile cream
RxNorm normalized name: Chamomile
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile cream
Trial: 8513841
Drug: Hamamelis PC-cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hamamelis PC-cream
Trial: 31808686
Drug: MHBAs (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHBAs (35 mg/day)
Trial: 28290272
Drug: SCP beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCP beverage (333 mg SCP) daily for 6 weeks
Trial: 28290272
Drug: Control beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control beverage (0 mg SCP)
Trial: 28290272
Drug: SCP beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCP beverage (333 mg SCP)
Trial: 21240015
Drug: Calcium 75
RxNorm normalized name: Calcium 750mg, Magnesium 465mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 75 mg · kg⁻¹ · day⁻¹ (high dose)
Trial: 21240015
Drug: Calcium 45
RxNorm normalized name: Calcium 45mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 45 mg · kg⁻¹ · day⁻¹ (low dose)
Trial: 18325386
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg orally twice daily
Trial: 16443339
Drug: Oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fat tolerance test (OFTT) in menopausal women with MetS
Trial: 7534055
Drug: Heparin-coated cardiopulmonary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated cardiopulmonary bypass
Trial: 8905004
Drug: Formoterol inhaled
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol inhaled via dry-powder (DP) capsule inhaler
Trial: 8905004
Drug: Formoterol inhaled
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol inhaled via pressurized metered-dose inhaler (pMDI)
Trial: 1910651
Drug: Weekly (intensive)
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly (intensive) neurodevelopmental therapy
Trial: 1910651
Drug: Monthly (basic)
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly (basic) neurodevelopmental therapy
Trial: 7082780
Drug: New enteric-coated
RxNorm normalized name: EC-0652
DrugBank: EC-0652 (DB15340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New enteric-coated phenylbutazone (100 mg and 200 mg)
Trial: 31861714
Drug: Lumbar lordotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar lordotic curve-controlled traction (L-LCCT)
Trial: 28615931
Drug: Indacaterol 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 150 µg
Trial: 9444800
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg prolonged-release capsule per day
Trial: 9444800
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg enteric-coated tablet every 8 hours
Trial: 8154260
Drug: Daily dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dietary supplement of a mixture consisting of vitamins (A, B1, B2, B6, E) and trace elements (calcium, iron, manganese)
Trial: 8154260
Drug: Daily dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dietary supplement of purely vitamin C tablets
Trial: 2876233
Drug: Higher-dose frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose frusemide
Trial: 29851760
Drug: 25 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 μg vitamin D supplements
Trial: 29851760
Drug: 10 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg vitamin D supplements
Trial: 29851760
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 μg)
Trial: 26099215
Drug: Riluzole 100
RxNorm normalized name: Riluzole
DrugBank: Riluzole (DB00740)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riluzole 100 mg BID for the first 24 hours followed by 50 mg BID for the following 13 days
Trial: 16670161
Drug: T(4) dosage
RxNorm normalized name: 4-T-BUTYLCYCLOHEXANOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T(4) dosage adjustment aiming for serum TSH concentration less than 2 mU/liter
Trial: 16670161
Drug: T(4) dosage
RxNorm normalized name: 4-T-BUTYLCYCLOHEXANOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T(4) dosage adjustment aiming for serum TSH concentration in the upper reference range
Trial: 11512311
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) as part of immunosuppression therapy
Trial: 11512311
Drug: Azathioprine as
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine as part of immunosuppression therapy
Trial: 8863274
Drug: 0.1% oral
RxNorm normalized name: BARIUM SO4 0.1% ORAL SUSP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% oral rinse
Trial: 8863274
Drug: 0.5% oral
RxNorm normalized name: PHENOL 0.5% ORAL SPRAY TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% oral rinse
Trial: 8863274
Drug: 0.01% oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01% oral rinse
Trial: 8863274
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg peroral ketorolac capsule
Trial: 31264800
Drug: Mindfulness-Based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-Based Cognitive Therapy for Children (MBCT-C)
Trial: 22135277
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg p.o. q.d. for 5 days
Trial: 22135277
Drug: Amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid 875/125 mg p.o. b.i.d. for 7 days
Trial: 20568520
Drug: Muscle-derived stem
RxNorm normalized name: Allogenic bone marrow-derived mesenchymal stem cells
DrugBank: Allogenic bone marrow-derived mesenchymal stem cells (DB18032)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscle-derived stem cells (MDSCs) therapy
Trial: 20568520
Drug: Mesenchymal stem
RxNorm normalized name: Human mesenchymal stem cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesenchymal stem cells (MSCs) therapy
Trial: 10799631
Drug: 3.5 mL
RxNorm normalized name: ethanol 3.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 mL of undiluted albuterol nebulized for 20 inhalations every 20 minutes for a total of 3 treatments.
Trial: 10799631
Drug: Albuterol diluted
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol diluted (0.5 mL) and nebulized in normal saline (3 mL) every 20 minutes for a total of 3 treatments.
Trial: 10799631
Drug: Study group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Study group (undiluted albuterol)
Trial: 10799631
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (diluted albuterol)
Trial: 8967585
Drug: Isoflurane using
RxNorm normalized name: Isoflurane
DrugBank: Isoflurane (DB00753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoflurane using a low-flow system (fresh gas flow 2 l/min)
Trial: 1640029
Drug: Combined approach
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined approach (SDD) of oropharyngeal, gastrointestinal and parenteral use of certain antibiotics
Trial: 30991815
Drug: Topical ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ciprofloxacin (intraoperative plus 5 days)
Trial: 29974433
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal tablets (FBT) 100 μg (group A)
Trial: 29974433
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal tablets (FBT) 200 μg (group B)
Trial: 29974433
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal tablets (FBT)
Trial: 24271646
Drug: Opicapone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opicapone (50 mg oral dose) in patients with moderate liver impairment
Trial: 24271646
Drug: Opicapone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opicapone (50 mg oral dose) in healthy subjects (control)
Trial: 23022943
Drug: Miracle Fruit™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miracle Fruit™ supplement
Trial: 10545689
Drug: NIHSS administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIHSS administered by neurologists
Trial: 10545689
Drug: NIHSS administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIHSS administered by research nurses
Trial: 10545689
Drug: NIHSS administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIHSS administered by research nurses and neurologists
Trial: 376210
Drug: Clonidine three
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine three times a day with a diuretic
Trial: 376210
Drug: Clonidine twice
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine twice a day with a diuretic
Trial: 30739176
Drug: Ectoine lozenges
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ectoine lozenges
Trial: 30739176
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid lozenges
Trial: 25872171
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus lornoxicam
Trial: 21377715
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal (48% fat, 49 g)
Trial: 21377715
Drug: Low-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat meal (15% fat, 3 g)
Trial: 21377715
Drug: High-trans fatty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-trans fatty acid meal (5.2 g trans fat)
Trial: 21377715
Drug: Nontrans fatty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nontrans fatty acid meal (<0.3 g trans fat)